Prostate Cancer

PROSTATE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

MRI-Based Algorithm More Predictive of Biochemical Recurrence After Prostate Cancer Surgery Than Existing Prognostic Tools

A retrospective study found that a radiomic-clinicopathologic nomogram performed better than other tools in predicting biochemical recurrence-free survival after surgery for prostate cancer.
First GnRH Receptor Antagonist Enters Advanced Prostate Cancer Treatment Portfolio

Daniel J. George, MD, a lead investigator on the HERO study, discusses the implications of relugolix’s approval for advanced prostate cancer.
Use of Commercial Genomic Testing for Prostate Cancer ‘Highly Variable’ in the United States

Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.
Biosimilars in Cancer Care: Insights From 2020 and Expectations for 2021

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, and Brian Ansay, senior vice president of Sales and Corporate Services at ION Solutions, review 2020 biosimilar trends in oncology and forecast what is ahead in 2021.
NCI-MATCH Trial Identifies Actionable Alterations in More Than One-Third of Patients With Cancer

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.

PROSTATE CANCER NEWS

Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward

May 5, 2021

Cryoablation needles are inserted through the perineum into the prostate.

Salvage Cryotherapy for Recurrent PCa May Provide Long-Term Oncologic Control

May 4, 2021

AUA 2017, senior patient, doctor, consultation, doctor and patient talking, office, urology, nephrol

Prostate Cancer ADT Not Linked to Greater Cardiovascular Mortality

May 3, 2021

Black and White Men Had Similar Outcomes After Radical Prostatectomy

April 28, 2021

Early PSA Response to Abiraterone Predicts Better Outcomes

Nonmetastatic CRPC Treatments Compared for Efficacy and Safety

April 26, 2021

Next post in Prostate Cancer

AUA 2017, senior patient, doctor, consultation, doctor and patient talking, office, urology, nephrol

Prostate Cancer ADT Not Linked to Greater Cardiovascular Mortality